SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $631,544 | -59.8% | 135,816 | -60.1% | 0.00% | -50.0% |
| Q1 2023 | $1,572,703 | -18.2% | 340,412 | +43.1% | 0.00% | -33.3% |
| Q4 2022 | $1,922,192 | +95.5% | 237,895 | +34.3% | 0.01% | +100.0% |
| Q3 2022 | $983,000 | +3.1% | 177,089 | -3.2% | 0.00% | 0.0% |
| Q2 2022 | $953,000 | -28.8% | 182,896 | +12.3% | 0.00% | -25.0% |
| Q1 2022 | $1,339,000 | -20.4% | 162,912 | +44.1% | 0.00% | 0.0% |
| Q4 2021 | $1,683,000 | -60.8% | 113,083 | -50.3% | 0.00% | -60.0% |
| Q3 2021 | $4,297,000 | +13.3% | 227,481 | +11.5% | 0.01% | +11.1% |
| Q2 2021 | $3,793,000 | +40.6% | 204,044 | +72.2% | 0.01% | +28.6% |
| Q1 2021 | $2,697,000 | +154.2% | 118,510 | +142.6% | 0.01% | +133.3% |
| Q4 2020 | $1,061,000 | -2.0% | 48,852 | -54.7% | 0.00% | -25.0% |
| Q3 2020 | $1,083,000 | – | 107,731 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |